Trials / Conditions / Cholangiocarcinoma Resectable
Cholangiocarcinoma Resectable
6 registered clinical trials studyying Cholangiocarcinoma Resectable — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary T NCT07454486 | Aarhus University Hospital | — |
| Not Yet Recruiting | Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA NCT06569225 | University Health Network, Toronto | Phase 2 |
| Recruiting | Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Pati NCT06730009 | Medigen Biotechnology Corporation | Phase 1 / Phase 2 |
| Completed | Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC) NCT06381648 | City of Hope Medical Center | — |
| Not Yet Recruiting | Neoadjuvant PDT in the Treatment of Cholangiocarcinoma NCT04824742 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Completed | Recurrence After Whipple's (RAW) Study NCT04596865 | University Hospital Plymouth NHS Trust | — |